CANC

Tema Oncology ETF

Jan 26 • 04:00PM ET

36.51

-0.40 -1.08 %

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	46.32%	Total Holdings	57	Perf Week	0.63%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	AUM	142.83M	Perf Month	2.99%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	NAV/sh		Perf Quarter	22.60%
Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	37.51 -2.67%	Perf Half Y	35.52%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	20.10 81.68%	Perf YTD	5.15%
Active/Passive		Quant Type		Tags	-	Flows% 1M	19.49%	Volatility	1.78% 2.00%	Perf Year	42.34%
Dividend TTM	0.02 (0.05%)	ESG Type		Tags	-	Flows% 3M	37.31%	ATR (14)	0.75	Perf 3Y	-
Dividend Ex-Date	Dec 10, 2025	Dividend Type		Sector/Theme		Flows% YTD	16.39%	RSI (14)	56.17	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.97	Perf 10Y	-
Expense	0.75%	Growth/Value		SMA20	1.64%	Flows% 3Y		Rel Volume	0.75	Prev Close	36.91
Inverse/Leveraged		Market Cap		SMA50	3.90%	Flows% 5Y		Avg Volume	33.49K	Price	36.51
IPO	Aug 16, 2023	Option/Short	No / Yes	SMA200	27.65%	Trades		Volume	25,206	Change	-1.08%

Jan-09-26 10:00AM	Here's Why Biotech ETFs Are Rallying Hard (Zacks)
Dec-02-25 06:00AM	Temas Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance (Business Wire)
Nov-26-25 10:00AM	Be Thankful to These ETFs This Year (Zacks)
Nov-21-25 08:00AM	Inside the Recent Strength in Biotech ETFs (Zacks)
Oct-20-25 06:00AM	Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience